Trials / Completed
CompletedNCT02979223
Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation
Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- National Cancer Center, Korea · Other Government
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to compare the efficacy depending on the order of the sequential combination method using sodium picosulfate and magnesium citrate (PMC) and PEG with ascorbic acid for bowel preparation. The investigators designed this study as a phase II prospective randomized parallel arm clinical trial. 71 participant will be enrolled in each group (142 in total). The primary outcome is the efficacy of bowel preparation. secondary outcomes are tolerability, side effect of the drugs, polyp detection rate and adenoma detection rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acid | sodium picosulfate and magnesium citrate and 2L polyethylene glycol with ascorbic acid are used as combination method. There is a difference in the order of intake between two group |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-12-01
- Last updated
- 2019-08-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02979223. Inclusion in this directory is not an endorsement.